In The News

You are here

Milestone Clinical Trial for DIPG Approved

Dr. Mark Souweidane, Director of Pediatric Neurological Surgery, has received FDA approval for a clinical trial for young patients diagnosed with Diffuse Intrinsic Pontine Glioma (DIPG).

Dr. Theodore Schwartz Publishes Results of Promising Epilepsy Research

Nearly a third of all epilepsy patients do not respond to conventional drug treatments, and only a fraction of those are candidates for surgical solutions. New research published in the journal Neurotherapeutics holds promise for an alternative approach. Dr. Theodore Schwartz of the Weill Cornell Brain and Spine Center collaborated with Dr. Stewart Anderson from the Department of Psychiatry in a newly released study that shows how brain cell transplants stopped seizures in a rat model.

Dr. Boockvar Appears on The Dr. Oz Show

Dr. Boockvar on The Dr. Oz Show

Dr. John Boockvar made two appearances on The Dr. Oz Show to discuss brain tumors and their risk factors. Watch the videos.

Six Weill Cornell Neurosurgeons Named as U.S. News Top Doctors

We're proud to have six of our neurosurgeons on this first edition of the magazine's list of top doctors.

Dr. Theodore H. Schwartz and Dr. A. Gabriella Wernicke Achieve Breakthrough Use of Cesium-131 for Intracavitary Brachytherapy in Malignant Brain Tumor

Intracavitary brachytherapy is a minimally invasive technique used to line a surgical cavity with radioactive seeds — cancer-fighting radioisotopes encased in capsules the size of a rice grain — after removal of malignant disease. This procedure delivers high-dose radiation to the tumor cavity margin to prevent recurrence of microscopic disease in patients with malignant brain tumors.

Pages